Clinical characteristics and natural course of chronic obstructive pulmonary disease and/or asthma in Japanese patients: a summary report of two Hokkaido-based cohort studies

被引:2
作者
Suzuki, Masaru [1 ,3 ]
Makita, Hironi [1 ,2 ]
Konno, Satoshi [1 ]
Nishimura, Masaharu [1 ,2 ]
机构
[1] Hokkaido Univ, Fac Med, Dept Resp Med, Sapporo, Japan
[2] Hokkaido Med Res Inst Resp Dis, Sapporo, Japan
[3] Hokkaido Univ, Fac Med, Dept Resp Med, North 15 West 7,Kita ku, Sapporo 0608638, Japan
基金
日本学术振兴会;
关键词
COPD; Asthma; Cohort study; Japanese; AIR-FLOW LIMITATION; COMPUTED-TOMOGRAPHY; BRONCHODILATOR RESPONSES; GENE PROMOTER; ANTICHOLINERGIC AGENTS; EXERCISE CAPACITY; COPD; EMPHYSEMA; POLYMORPHISMS; ASSOCIATION;
D O I
10.1016/j.resinv.2023.05.002
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Chronic obstructive pulmonary disease (COPD) and asthma are the most common chronic airway diseases and are characterized by chronic airway inflammation and airflow limita-tion. Japanese patients with COPD or asthma have characteristics different from those of Westerners. Therefore, understanding the characteristics and clinical course of Japanese patients with COPD and those with asthma, particularly severe asthma, is critical for their management and appropriate treatment. The Hokkaido COPD cohort and Hokkaido-based Investigative Cohort Analysis for Refractory Asthma (Hi-CARAT) are high-quality cohort studies of COPD and asthma in the Japanese population and provide valuable data. This report summarizes the clinical findings from the two cohort studies and provides data for more appropriate management of Japanese patients with COPD and/or asthma. Overall, 279 patients with COPD were followed up for up to 10 years in the Hokkaido COPD cohort study, and 127 with severe asthma were followed up for up to 6 years in the Hi-CARAT study. Seventy-nine patients with mild-to-moderate asthma provided baseline data for the Hi -CARAT study. In each disease, several distinct factors, including systemic status and non -pulmonary factors, were associated with important clinical outcomes, such as lung func-tion decline, exacerbations, impaired quality of life, and mortality. Therefore, multifaceted evaluation based on the characteristics of the Japanese population is necessary for the management of COPD and asthma.& COPY; 2023 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:527 / 539
页数:13
相关论文
共 88 条
[1]   Blood eosinophil count variability in chronic obstructive pulmonary disease and severe asthma [J].
Abe, Yuki ;
Suzuki, Masaru ;
Kimura, Hirokazu ;
Shimizu, Kaoruko ;
Takei, Nozomu ;
Oguma, Akira ;
Matsumoto-Sasaki, Machiko ;
Goudarzi, Houman ;
Makita, Hironi ;
Nishimura, Masaharu ;
Konno, Satoshi .
ALLERGOLOGY INTERNATIONAL, 2023, 72 (03) :402-410
[2]   Annual Body Weight Change and Prognosis in Chronic Obstructive Pulmonary Disease [J].
Abe, Yuki ;
Suzuki, Masaru ;
Shima, Hiroshi ;
Shiraishi, Yusuke ;
Tanabe, Naoya ;
Sato, Susumu ;
Shimizu, Kaoruko ;
Kimura, Hirokazu ;
Makita, Hironi ;
Hirai, Toyohiro ;
Konno, Satoshi ;
Nishimura, Masaharu .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 :3243-3253
[3]   One-year clinically important deterioration and long-term clinical course in Japanese patients with COPD: a multicenter observational cohort study [J].
Abe, Yuki ;
Suzuki, Masaru ;
Makita, Hironi ;
Kimura, Hirokazu ;
Shimizu, Kaoruko ;
Konno, Satoshi ;
Nishimura, Masaharu .
BMC PULMONARY MEDICINE, 2021, 21 (01)
[4]   Annual Fractional Exhaled Nitric Oxide Measurements and Exacerbations in Severe Asthma [J].
Abe, Yuki ;
Suzuki, Masaru ;
Kimura, Hirokazu ;
Shimizu, Kaoruko ;
Makita, Hironi ;
Nishimura, Masaharu ;
Konno, Satoshi .
JOURNAL OF ASTHMA AND ALLERGY, 2020, 13 :731-741
[5]  
[Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341
[6]  
[Anonymous], 1995, Global Strategy for Asthma Management and Prevention
[7]  
[Anonymous], GLOBAL STRATEGY DIAG
[8]   THE COURSE AND PROGNOSIS OF DIFFERENT FORMS OF CHRONIC AIRWAYS OBSTRUCTION IN A SAMPLE FROM THE GENERAL-POPULATION [J].
BURROWS, B ;
BLOOM, JW ;
TRAVER, GA ;
CLINE, MG .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (21) :1309-1314
[9]   Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease [J].
Calverley, Peter M. A. ;
Anderson, Julie A. ;
Celli, Bartolome ;
Ferguson, Gary T. ;
Jenkins, Christine ;
Jones, Paul W. ;
Yates, Julie C. ;
Vestbo, Jorgen ;
Calverley, P. M. A. ;
Anderson, J. A. ;
Celli, B. ;
Ferguson, G. T. ;
Jenkins, C. ;
Jones, P. W. ;
Knobil, K. ;
Yates, J. C. ;
Vestbo, J. ;
Cherniack, R. ;
Similowski, T. ;
Cleland, J. ;
Whitehead, A. ;
Wise, R. ;
McGarvey, L. ;
John, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :775-789
[10]   Bronchodilator reversibility testing in chronic obstructive pulmonary disease [J].
Calverley, PMA ;
Burge, PS ;
Spencer, S ;
Anderson, JA ;
Jones, PW .
THORAX, 2003, 58 (08) :659-664